Hipragumboro CH 80 is a live intermediate vaccine for protection against GUMBORO disease in poultry. HIPRAGUMBORO® CH80 produces moderate bursal depletion which prevents immunosuppression from occurring in the birds.
If the birds are infected, the bursa of Fabricius will be effectively protected and with the functionality of the organ mantained (humoral and cellular immunity remain functional in the vaccinated birds).
It is an intermediate strain with an average score of bursal lesion not higher than 2.0 (on a scale of 0-5) at 21 days post-vaccination and not higher than 1.2 at 28 days after administration of a 10 times maximum dose.
Benefits:
• A high immune response
• Low interference with maternal antibodies
• Great genetic stability (no reversion to virulence)
• Improved production quality
• High repeatability between batches.
No reviews found